Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus

Amir H. Lebastchi, Arvin K. George, Thomas J. Polascik, Jonathan Coleman, Jean de la Rosette, Baris Turkbey, Bradford J. Wood, Michael A. Gorin, Abhinav Sidana, Sangeet Ghai, Kae Jack Tay, John F. Ward, Rafael Sanchez-Salas, Berrend G. Muller, Bernard Malavaud, Pierre Mozer, Sebastien Crouzet, Peter L. Choyke, Osamu Ukimura, Ardeshir R. RastinehadPeter A. Pinto

Research output: Contribution to journalArticlepeer-review

64 Scopus citations

Abstract

In this report, we present expert opinion on the use of a standardized nomenclature and surveillance methodologies after focal therapy and partial gland ablation for localized prostate cancer. The panel recommends the use of the proposed nomenclature and follow-up protocols to generate reliable data supporting a broader implementation of focal therapy as a standard of care for select patients with localized prostate cancer.

Original languageEnglish (US)
Pages (from-to)371-378
Number of pages8
JournalEuropean urology
Volume78
Issue number3
DOIs
StatePublished - Sep 2020

Keywords

  • Focal therapy
  • Nomenclature
  • Partial gland ablation
  • Surveillance

ASJC Scopus subject areas

  • Urology

Fingerprint

Dive into the research topics of 'Standardized Nomenclature and Surveillance Methodologies After Focal Therapy and Partial Gland Ablation for Localized Prostate Cancer: An International Multidisciplinary Consensus'. Together they form a unique fingerprint.

Cite this